Menu
Home
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Misc
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Labrish
Nyuuz
Dr Amos Msekandiana to lead Kamuzu Central Hospital
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
[QUOTE="Munyaradzi Mafaro, post: 70568, member: 636"] The Malawi government has named Dr. Amos Msekandiana as Hospital Director at Kamuzu Central Hospital in Lilongwe, where he will take charge of tertiary healthcare services for the region. Recognized as the country's first endocrinologist and pediatric specialist, Dr. Msekandiana brings extensive experience from previous positions, including Country Director of Baylor College of Medicine and Clinical Senior Lecturer at Kamuzu University of Health Sciences. Dr. Msekandiana earned his medical degree from the College of Medicine at the University of Malawi and completed advanced training in pediatric medicine and tropical medicine. His credentials include fellowship status with the Pediatric Endocrinology Training Center for Africa, demonstrating specialized expertise in endocrine disorders affecting children. The Ministry of Health anticipates that Dr. Msekandiana's clinical knowledge and management capabilities will enhance patient care and hospital operations. He replaces Dr. Enoch, who has transferred to Mzuzu Central Hospital. [/QUOTE]
Insert quotes…
Name
Post reply
Home
Forums
Labrish
Nyuuz
Dr Amos Msekandiana to lead Kamuzu Central Hospital
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top